REPH LOSS NOTICE: Rosen Law Firm Announces Filing of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
730
REPH LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Recro Pharma, Inc.– REPH

NEW YORK, June 16, 2018 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Recro Pharma, Inc. (NASDAQ: REPH) from July 31, 2017 through May 23, 2018, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Recro Pharma investors under the federal securities laws.

To join the Recro Pharma class action, go to http://www.rosenlegal.com/cases-1349.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or   zhalper@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION.  UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Recro Pharma’s lead product,  IV meloxicam, lacked supporting clinical data to show sufficient clinical benefits to receive U.S. Food and Drug Administration approval; and (2) as a result, Recro’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 30, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1349.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or zhalper@rosenlegal.com .

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm .

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.

-------------------------------

Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Zachary Halper, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34 th Floor New York, NY  10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com zhalper@rosenlegal.com www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Essity's Recent Share Buyback: What You Need to Know

Updated Category News Views 154

Essity's Commitment to Share Buybacks In recent developments, Essity Aktiebolag (publ) has embarked on a strategic journey involving the repurchase of Class B shares. From November 4 to November 8, 2024, the company successfully bought back a total of 270,000 of its own Class B shares. This initiative is part of a broader buyback program that aims to enhance shareholder...

Continue Reading
Michael Kalen Steers Eagle Rock Wealth for Big Growth

Updated Category News Views 6

Michael Kalen Takes Charge at Eagle Rock Wealth Now, here's a development that should make investors sit up and take notice: Michael Kalen has been named President of Eagle Rock Wealth, one of the big shots in private wealth management. With a history mired in leadership across major financial sectors, Kalen isn't your run-of-the-mill executive. His past gigs as President...

Continue Reading
Veris Residential's $3.4B Acquisition: Cashing In Big Time

Updated Category News Views 195

Veris Residential Seals the Deal A big shake-up in the multifamily REIT market—Veris Residential (NYSE:VRE) just got the green light for a whopping acquisition by Affinius Capital and pals, all to the tune of $3.4 billion in cash. Yep, you heard that right. Shareholders are looking at a sweet $19.00 per share coming their way. That's a hefty 23.2% premium over the...

Continue Reading
Kairon Labs and Solidus Labs Join Forces for Market Integrity

Updated Category News Views 281

Kairon Labs Partners with Solidus Labs to Innovate Market Practices Kairon Labs, a leading crypto market maker and liquidity provider, has entered into a strategic partnership with Solidus Labs, a pioneer in crypto-native compliance and risk management solutions. This collaboration is focused on enhancing Kairon Labs' compliance program in anticipation of the European...

Continue Reading
Investors Facing Class Action Lawsuits: Indivior, CrowdStrike, DXC, Five Below

Updated Category News Views 194

Update on Class Action Lawsuits Involving Major Stocks Investors, especially those holding shares in important companies, are currently facing a series of class action lawsuits. Renowned law firm Bragar Eagel & Squire, P.C. has announced the initiation of class actions against Indivior PLC (NASDAQ: INDV), CrowdStrike Holdings, Inc. (NASDAQ: CRWD), DXC Technology Company...

Continue Reading